5-alpha-reductase deficiency: Difference between revisions

	5-alpha-reductase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 5-alpha-reductase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Molecular Genetic Studies
Genotyping
Pelvic X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
5-alpha-reductase deficiency On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 5-alpha-reductase deficiency All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 5-alpha-reductase deficiency
CDC on 5-alpha-reductase deficiency
5-alpha-reductase deficiency in the news
Blogs on 5-alpha-reductase deficiency
Directions to Hospitals Treating 5-alpha-reductase deficiency
Risk calculators and risk factors for 5-alpha-reductase deficiency

	5-alpha-reductase deficiency;
	5-alpha reductase produces dihydrotestosterone
ICD-10	E29.1, Q56.3
ICD-9	257.2, 752.7
OMIM	264600
DiseasesDB	11

VisualWikitext

Latest revision as of 19:57, 19 September 2012

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 5-alpha-reductase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

External links

OMIM article
5-Alpha-Reductase Deficiency at eMedicine
"Whatever I feel..." Article in the New Internationalist

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
-'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
+__NOTOC__
 {{Infobox_Disease |
    Name           = 5-alpha-reductase deficiency |
@@ Line 10: / Line 10: @@
    OMIM           = 264600 |
    MedlinePlus    = |
-  eMedicineSubj  = ped |
-  eMedicineTopic = 1980 |
    MeshName       = |
    MeshNumber     = |
 }}
-{{Search infobox}}
+'''For patient information, click [[5-alpha-reductase_deficiency (patient information)|here]]'''
+{{5-alpha-reductase deficiency}}
 {{CMG}}
+==[[5-alpha-reductase deficiency overview|Overview]]==
-{{Editor Join}}
+==[[5-alpha-reductase deficiency historical perspective|Historical Perspective]]==
-==Overview==
+==[[5-alpha-reductase deficiency classification|Classification]]==
-'''5-alpha-reductase deficiency''' ('''5-ARD''') is an [[autosomal recessive]] disorder of sex development (DSD, formerly known as [[intersex]]) caused by a [[genetic mutation|mutation]] of the [[5-alpha reductase]] type 2 [[gene]].<ref name="Gpnotebook">{{GPnotebook|852492298}}</ref>
-==Normal function==
+==[[5-alpha-reductase deficiency pathophysiology|Pathophysiology]]==
-'''[[5-alpha-reductase]]''' is an [[enzyme]] that converts [[testosterone]] to [[dihydrotestosterone]] (DHT) in peripheral tissues. 5-alpha-reductase deficiency-2 is biochemically characterized by low to low normal levels of testosterone and decreased levels of 5α-DHT, creating a higher testosterone/DHT ratio.
-[[Image:Test biosynth 5ARD2.jpg|thumb|center|680px| Biochemical effects of 5-alpha-reductase deficiency-2 in testosterone biosynthesis. Typically levels of testosterone are elevated, while levels of DHT are significantly decreased, leading to male [[undervirilization]].]]
-DHT is a potent [[androgen]], necessary for the development of male external [[genitalia]] in utero.
+==[[5-alpha-reductase deficiency causes|Causes]]==
-==Signs==
+==[[5-alpha-reductase deficiency differential diagnosis|Differentiating 5-alpha-reductase deficiency from other Diseases]]==
-The condition affects only males (i.e. those with a [[Y chromosome]]) because DHT has no known role in female development.<ref>[http://www.emedicine.com/ped/topic1980.htm eMedicine article on 5-ARD]</ref>
-Individuals with 5-ARD can have normal male external genitalia, [[ambiguous genitalia]], or normal female genitalia. They are born with [[male]] [[gonad]]s, including [[testicles]] and [[Wolffian structures]], but usually appear to have [[female]] [[primary sex characteristic]]s. Consequently they are often raised as girls and develop a female [[gender identity]]. Individuals with obvious [[virilisation|undervirilisation]] at birth, eg. hypospadia, micropenis or complete [[ambiguous genitalia]] are currently raised as boys.
+==[[5-alpha-reductase deficiency epidemiology and demographics|Epidemiology and Demographics]]==
-In individuals with feminised or ambiguous genitalia, there is a tendency towards an enlarged [[clitoris]], or [[micropenis|microphallus]], and the [[urethra]] may attach to the phallus. This structure may be capable of erections as well as ejaculations. Individuals with 5-ARD are generally capable of producing viable [[sperm]], however [[artificial insemination]] techniques or [[in-vitro fertilisation]] are necessary.
+==[[5-alpha-reductase deficiency risk factors|Risk Factors]]==
-At [[puberty]], individuals often have primary [[amenorrhoea]], and may experience [[virilisation]]. This may include descending of the testes, [[hirsuitism]] and deepening of the voice. In adulthood, individuals do not experience male-pattern baldness.<ref name="Gpnotebook"/> As DHT is a far more potent androgen than testosterone alone, virilisation in those lacking DHT may be absent or reduced compared to males with functional 5-alpha reductase. It is hypothesized that rising testosterone levels at the start of puberty (around age twelve) are able to generate sufficient levels of DHT by either the action of 5-alpha-reductase type 1 (active in the adult liver, non-genital skin and some brain areas) or through the expression of low levels of 5-alpha-reductase type 2 in the testes.
+==[[5-alpha-reductase deficiency screening|Screening]]==
-==Complications==
+==[[5-alpha-reductase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
-With 5-ARD there is a risk of gender identity disorder as well as infertility, due to underdevelopment of seminal vesicles and prostate.
-===Gender identity disorder===
+==Diagnosis==
-Although most people with 5-ARD identify themselves as females, some, however, may develop a male gender identity coinciding the with the pubertal [[virilisation]], or can present themselves with apparent gender dysphoria and transgender behavior. Most cases of gender (role) changes have been reported in large families in the Dominican Republic and Sao Pablo. It is unclear if these patients had the means or possibilities to be treated against virilisation. In some cultures it seems to be socially more beneficial to be a man, than an infertile woman. It is unclear whether this has played any part in the above mentioned gender changes.
+[[5-alpha-reductase deficiency history and symptoms|History and Symptoms]] | [[5-alpha-reductase deficiency physical examination|Physical Examination]] | [[5-alpha-reductase deficiency laboratory findings|Laboratory Findings]] | [[5-alpha-reductase deficiency molecular_genetic_studies|Molecular Genetic Studies]] | [[5-alpha-reductase deficiency genotyping|Genotyping]] | [[5-alpha-reductase deficiency pelvic x ray|Pelvic X Ray]] | [[5-alpha-reductase deficiency CT|CT]] | [[5-alpha-reductase deficiency ultrasound|Ultrasound]] | [[5-alpha-reductase deficiency other imaging findings|Other Imaging Findings]] | [[5-alpha-reductase deficiency other diagnostic studies|Other Diagnostic Studies]]
-===Infertility===
+==Treatment==
-There is an increased risk of [[cryptorchidism]] in 5-ARD, causing infertility, but also a higher risk of [[testicular cancer]]. Fertility is further compromised by the underdevelopment of seminal vesicles and prostate.
+[[5-alpha-reductase deficiency medical therapy|Medical Therapy]] | [[5-alpha-reductase deficiency primary prevention|Primary Prevention]] | [[5-alpha-reductase deficiency secondary prevention|Secondary Prevention]] | [[5-alpha-reductase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[5-alpha-reductase deficiency future or investigational therapies|Future or Investigational Therapies]]
-On the other hand, fertility depending on the female characteristics are impossible; Although the external genitalia appear female, the "pseudovagina" consists only of the lower two-thirds of a normal vagina; creating a blind-ending vaginal pouch. Due to the normal action of [[Anti-müllerian hormone|Müllerian inhibiting factor]] produced by the [[testis]] in utero, individuals with 5-ARD lack a [[uterus]] and [[Fallopian tube]]s. Thus, individuals with 5-ARD are not able to become pregnant or produce ova.
+==Case Studies==
-==Prevalence==
+[[5-alpha-reductase deficiency case study one|Case #1]]
-The number of people with this condition varies geographically, depending on how much of a given population is interrelated. In 1974, Jullianne Imperato-McGinley has estimated an incidence of 1:90 males in the Dominican Republic. This can be seen in that certain regions have evolved terminology for the condition:
-===Local names===
-The term '''Guevedoche''' or Guevedoces is Spanish slang for the condition. It originated in the Dominican Republic where more than three dozen cases have occurred in the small village of Salinas, all descended from a single individual named Altagracia Carrasco. It stands for the vulgar expression ''huevo a los doce'', which translates literally as "balls at twelve". It is also known locally as 'Machihembras' ('first women, then man').
-A similar cluster of cases among the Simbari of the Eastern Highlands of Papua New Guinea has the local name 'Kwolu-aatmwol' ('female thing transforming into male thing').
-== Popular culture ==
-* Jeffrey Eugenides won a Pulitzer Prize for his 2002 novel ''Middlesex'', which explores this deficiency.
-* The Carver, a character on the television show ''Nip/Tuck'', has this condition.
-* Documentaries on the condition include "Guevote: The Way I Feel Is How I Am" ("Guevote: So wie ich mich fuehle, bin ich"), 1996, by filmmaker Rolando Sánchez,<ref>[http://www.german-cinema.de/app/filmarchive/film_view.php?film_id=131 Guevote - The Way I Feel Is How I Am (Guevote - So wie ich mich fuehle, bin ich)]</ref> and "The Fight to be Male", 1979, British Broadcasting Company.
-==References==
-{{reflist}}
 ==See also==
 *[[Third sex]]
 *[[Intersexuality]]
-:*[[17-beta-hydroxysteroid dehydrogenase deficiency]]
+:*[[5-alpha-reductase deficiency]]
 :*[[Androgen insensitivity syndrome]]
 :*[[Gonadal dysgenesis]]
@@ Line 79: / Line 58: @@
 *[http://www.newint.org/issue300/trans.html "Whatever I feel..."] Article in the New Internationalist
+{{Endocrine pathology}}
-{{Endocrine pathology}}
+{{WikiDoc Help Menu}}
+{{WikiDoc Sources}}
 [[Category:Intersexuality]]
 [[Category:Endocrinology]]
-{{SIB}}
+[[Category:Patient information]]
-{{WikiDoc Help Menu}}
+[[Category:Disease]]
-{{WikiDoc Sources}}

v t e Endocrine pathology: endocrine diseases (E00-35, 240-259)
Thyroid	Hypothyroidism (Iodine deficiency, Cretinism, Congenital hypothyroidism, Goitre, Myxedema) - Hyperthyroidism (Graves disease, Toxic multinodular goitre, Teratoma with thyroid tissue or Struma ovarii) - Thyroiditis (De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis) - Euthyroid sick syndrome
Pancreas	Diabetes mellitus (type 1, type 2, coma, angiopathy, ketoacidosis, nephropathy, neuropathy, retinopathy) - Hypoglycemia - Hyperinsulinism - Zollinger-Ellison syndrome - insulin receptor (Rabson-Mendenhall syndrome)
Parathyroid	Hypoparathyroidism (Pseudohypoparathyroidism) - Hyperparathyroidism (Primary, Secondary, Tertiary)
Pituitary	Hyperpituitarism (Acromegaly, Hyperprolactinaemia, SIADH) - Hypopituitarism (Simmonds' disease / Sheehan's syndrome, Kallmann syndrome, Growth hormone deficiency, Diabetes insipidus) - Adiposogenital dystrophy - Empty sella syndrome - Hypophysitis
Adrenal	Cushing's syndrome (Nelson's syndrome, Pseudo-Cushing's syndrome) - CAH (Lipoid, 3β, 11β, 17α, 21α) - Hyperaldosteronism (Conn syndrome, Bartter syndrome) - Adrenal insufficiency (Addison's disease) - Hypoaldosteronism
Gonads	Ovarian dysfunction (Polycystic ovary syndrome, Premature ovarian failure) - Testicular dysfunction (5-alpha-reductase deficiency) - Testosterone biosynthesis (17-beta-hydroxysteroid dehydrogenase deficiency) - General (Hypogonadism, Delayed puberty, Precocious puberty)
Other	Androgen insensitivity syndrome - Autoimmune polyendocrine syndrome - Carcinoid syndrome - Gigantism - Short stature (Laron syndrome, Psychogenic dwarfism) - Multiple endocrine neoplasia (1, 2) - Progeria - Woodhouse-Sakati syndrome


5-alpha-reductase deficiency
5-alpha reductase produces dihydrotestosterone
ICD-10	E29.1, Q56.3
ICD-9	257.2, 752.7
OMIM	264600
DiseasesDB	11

5-alpha-reductase deficiency: Difference between revisions

Latest revision as of 19:57, 19 September 2012

Diagnosis

Treatment

Case Studies

See also

External links

Navigation menu

Search